Sinopharm Group Co (HK:1099) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sinopharm Group Co. Ltd. has released its preliminary financial results for the first half of 2024, revealing a slight decrease in revenue and a notable decline in profits compared to the same period last year. Despite a 1.57% dip in revenue and a decrease in operating and total profits by over 25%, the company’s total assets increased by 8.06%, and net assets per share saw a marginal growth.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.